newsfilter
← Latest News
Business Wire·

ImmunoCellular Therapeutics Provides an Update on Recent 2012 Achievements and Anticipated Milestones

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) provided an update on recent 2012 achievements and anticipated milestones following the closing of its follow-on financing.